Glucotrack, Inc.
Nasdaq: GCTK
- Raised $500,000 (2024)
- 1 clinical trial, 1 active
- Founded 2010
Life science companies
Explore 13,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Harvard Apparatus Regenerative Technology, Inc.
OTC: HRGN
- Raised $700,000 (2026)
- 1 clinical trial, 1 active
- Founded 2012
HCW Biologics Inc.
Nasdaq: HCWB
- Raised $4 million (2026)
- 1 clinical trial, 1 active
- Founded 2018
ImmunoMolecular Therapeutics, Inc.
- Raised $7 million (2020)
- 1 clinical trial
- Research grants: $449,982
- Founded 2015
Invictus Medical, Inc.
- Raised $1.3 million (2018)
- 1 clinical trial
- Research grants: $443,226
- Founded 2010
Metame Health Inc.
- Raised $140,500 (2024)
- 1 clinical trial
- Research grants: $349,554
- Founded 2018
Mindsciences, Inc.
- Raised $2.4 million (2019)
- 1 clinical trial
- Research grants: $678,962
- Founded 2018
Moleculin Biotech, Inc.
Nasdaq: MBRX
- Raised $6 million (2016)
- 7 clinical trials, 1 active
- Founded 2015
MyoKardia, Inc.
- Raised $46 million (2015)
- 7 clinical trials
- Founded 2012
Notable Labs, Ltd.
- Raised $10 million (2023)
- 1 clinical trial
- Founded 2014
Novoron Bioscience, Inc.
- Raised $12 million (2022)
- Research grants: $9.8 million
Obsidian Therapeutics, Inc.
Nasdaq: OBX
- Raised $32 million (2017)
- 1 clinical trial, 1 active
- Founded 2015
ONCOSEC MEDICAL Inc
- Raised $5.7 million (2017)
- 7 clinical trials
- Founded 2008
Personalis, Inc.
Nasdaq: PSNL
- Raised $12 million (2017)
- 1 clinical trial, 1 active
- Founded 2011
QHSLab, Inc.
OTC: USAQ
- Raised $626,548 (2026)
- 3 clinical trials, 2 active
QuidelOrtho Corp
Nasdaq: QDEL
- FDA-cleared or approved devices
RayzeBio, Inc.
- Raised $168 million (2022)
- 7 clinical trials, 7 active
- Founded 2020
Relypsa Inc
- Raised $65 million (2012)
- 7 clinical trials
- Founded 2007
Revelation Biosciences, Inc.
Nasdaq: REVB
- Raised $5.1 million (2021)
- 1 clinical trial
- Founded 2020
Saluda Medical, Inc.
- Raised $30 million (2025)
- 7 clinical trials, 3 active
- Founded 2023
Telomir Pharmaceuticals, Inc.
Nasdaq: TELO
- Raised $1 million (2023)
- 1 clinical trial, 1 active
- Founded 2021
Viela Bio, Inc.
- Raised $75 million (2019)
- 1 clinical trial
- Founded 2017
ZyVersa Therapeutics, Inc.
OTC: ZVSA
- Raised $419,320 (2022)
- 1 clinical trial
- Founded 2014
CVRx, Inc.
Nasdaq: CVRX
- Raised $50 million (2020)
- FDA-cleared or approved devices
Remmie, Inc
- Raised $100,000 (2021)
- 1 FDA-registered device site
- Research grants: $6.7 million
- Founded 2018
Semler Scientific, Inc.
- Raised $498,600 (2015)
- 2 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2013
Calyxo, Inc.
- Raised $40 million (2026)
- 5 clinical trials, 3 active
- FDA-cleared or approved devices
- Founded 2016
Assembly Biosciences, Inc.
Nasdaq: ASMB
- Raised $700,000 (2010)
- 29 clinical trials, 1 active
- Founded 2005
Calithera Biosciences, Inc.
- Raised $16 million (2014)
- 29 clinical trials
- Founded 2010
Cognita Labs, LLC
- 2 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $4.9 million
Glyphic Biotechnologies, Inc.
- Raised $33 million (2024)
- Research grants: $4.7 million
- Founded 2021
Immune-Onc Therapeutics, Inc.
- Raised $7 million (2016)
- 5 clinical trials, 1 active
- Research grants: $4.3 million
- Founded 2015
ProLynx, Inc.
- Raised $55,244 (2020)
- 1 clinical trial
- Research grants: $1.1 million
- Founded 2019
Serimmune Inc.
- Raised $12 million (2023)
- Research grants: $5.9 million
- Founded 2014
ZSX Medical, LLC
- Raised $235,200 (2020)
- 3 clinical trials
- Research grants: $6.4 million
Church & Dwight Co., Inc.
- 34 clinical trials
- FDA-cleared or approved devices
- 3 FDA-registered drug sites
Cytrellis Biosystems, Inc.
- Raised $25 million (2024)
- 10 clinical trials, 5 active
- FDA-cleared or approved devices
- Founded 2011
Levita Magnetics International Corp.
- Raised $31 million (2026)
- 10 clinical trials, 1 active
- FDA-cleared or approved devices
Altis Biosystems, Inc.
- Raised $2.1 million (2025)
- Research grants: $24 million
- Founded 2018
Alzheon, Inc.
- Raised $126 million (2025)
- 6 clinical trials, 1 active
- Founded 2013
Axonis Therapeutics, Inc.
- Raised $46 million (2024)
- Research grants: $7.6 million
BeyondSpring Inc.
Nasdaq: BYSI
- Raised $7.2 million (2017)
- 6 clinical trials, 1 active
- Founded 2014
Enzo Biochem Inc
- Raised $7 million (2023)
- Research grants: $1.6 million
Impulse Dynamics plc
- Raised $84 million (2025)
- 13 clinical trials, 6 active
Instylla, Inc.
- Raised $22 million (2025)
- 2 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2017
Jounce Therapeutics, Inc.
- Raised $35 million (2020)
- 6 clinical trials
- Founded 2012
Monopar Therapeutics
Nasdaq: MNPR
- Raised $2.1 million (2015)
- 6 clinical trials, 2 active
- Founded 2015
Natus Medical Inc
- FDA-cleared or approved devices
- Research grants: $99,998
Neurogene Inc.
Nasdaq: NGNE
- Raised $3.5 million (2011)
- 6 clinical trials, 2 active
- Founded 2007
Neurowave Systems Inc
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $5.7 million
Published company profiles only; counts update daily. Data licences